Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™
← catalyst calendarNCT02380092 · readout ≤ 1,015 d
Sponsored by Smith & Nephew, Inc. (industry) · SNN — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
163actual
Sites
7
Countries
Austria, Germany, Spain
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Sep 2015 | actual | When the study began enrolling |
| Primary completion | May 2029 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | May 2029 | estimated | The whole study's end, after follow-up |
| First posted | 2015-03-05 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-12-15 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Degenerative Joint Disease
Intervention
- Device: LEGION™ Primary TKS with VERILAST™ Bearing Surface
Primary outcome
what the primary-completion date above is the date OFSurvival
measured 10 years
Permalink · SNN's whole pipeline · Catalyst calendar · Every registered study · What changed